Search

Your search keyword '"Petteway S"' showing total 88 results

Search Constraints

Start Over You searched for: Author "Petteway S" Remove constraint Author: "Petteway S"
88 results on '"Petteway S"'

Search Results

6. Synthesis of a novel hematopoietic peptide, SK&F 107647

8. ChemInform Abstract: Synthesis and Antiviral Activity of a Novel Class of HIV-1 Protease Inhibitors Containing a Heterocyclic P1′-P2′ Amide Bond Isostere.

19. Antibodies reactive with human immunodeficiency virus gag-coded antigens (gag reactive only) are a major cause of enzyme-linked immunosorbent assay reactivity in a blood donor population

21. Structure−Activity Relationships of Novel Hematoregulatory Peptides

22. Expression and site-specific mutagenesis of the poliovirus 3C protease in Escherichia coli.

23. Purification and properties of thiol beta-lactamase. A mutant of pBR322 beta-lactamase in which the active site serine has been replaced with cysteine.

28. Immunoglobulin replacement therapy in primary antibody deficiency diseases--maximizing success.

29. Enveloped virus inactivation by caprylate: a robust alternative to solvent-detergent treatment in plasma derived intermediates.

30. Pathogen safety of manufacturing processes for biological products: special emphasis on KOGENATE Bayer.

31. Ensuring the pathogen safety of intravenous immunoglobulin and other human plasma-derived therapeutic proteins.

32. A direct relationship between the partitioning of the pathogenic prion protein and transmissible spongiform encephalopathy infectivity during the purification of plasma proteins.

33. Monitoring plasma processing steps with a sensitive Western blot assay for the detection of the prion protein.

34. HIV-1 membrane fusion mechanism: structural studies of the interactions between biologically-active peptides from gp41.

35. Structure-activity relationships of novel hematoregulatory peptides.

36. Potent inhibition of HIV type 1 infection of mononuclear phagocytes by synthetic peptide analogs of HIV type 1 protease substrates.

37. Efficacy of the hematoregulatory peptide SK&F 107647 in experimental systemic Candida albicans infections in normal and immunosuppressed mice.

38. In vivo modulation of hematopoiesis by a novel hematoregulatory peptide.

39. Synergistic drug interactions of an HIV-1 protease inhibitor with AZT in different in vitro models of HIV-1 infection.

40. V3 loop region of the HIV-1 gp120 envelope protein is essential for virus infectivity.

41. Human chromosome-dependent and -independent pathways for HIV-2 trans-activation.

42. Alteration of HIV-1 infectivity and neutralization by a single amino acid replacement in the V3 loop domain.

43. The chronically infected cell as a target for the treatment of HIV infection and AIDS.

45. Human chromosome 12 is required for elevated HIV-1 expression in human-hamster hybrid cells.

46. Anti-GP 120 antibodies from HIV seropositive individuals mediate broadly reactive anti-HIV ADCC.

47. Stable indicator cell lines exhibiting HIV-1 tat function.

48. The effects of hybrid ribosome-binding-site variants on the expression of human interferon-beta in Escherichia coli.

49. Chemical synthesis and expression of a gene encoding HIV-1 TAT protein.

50. Polymorphism of the 3' open reading frame of the virus associated with the acquired immune deficiency syndrome, human T-lymphotropic virus type III.

Catalog

Books, media, physical & digital resources